Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral v. Parenteral Medications for Acute Migraine
NCT05983354Withdrawn
- Sponsor
- Health Sciences North Research Institute
- Start
- Jun 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of metoclopramide, ibuprofen and ketorolac in migraine (2 arms), sponsored by Health Sciences North Research Institute. Primary endpoints: Recruitment rate at 6 months and Improvement in pain score at 60 minutes. Planned start Jun 2023; status: withdrawn.
02
Drugs
metoclopramideibuprofenketorolac
03
Conditions
migraine
Beyond the preview
Go deeper on NCT05983354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05983354.